- BTIG Reaffirms Ocular Therapeutix (OCUL) at 'Buy' Amid Regeneron (REGN) Collaboration; Offers Commentary -> Read this!
Streetinsider.com's Hot Lunchtime Reads 10/14: (WBA) (SSYS) (OCUL) (HAS) (SYT)
- Wall Street rises, buoyed by economic data; Dow sets high
- Twitter (TWTR) 'Takeover Money' Moves On as 'Trump Money' Moves In
- Amazon (AMZN) Could Open Over 2,000 Brick-and Mortar Groceries if Tests Succeed - DJ; Kroger (KR) on Watch
- Buy Any Seasonal Market Weakness Ahead of Year End Rally - Oppenheimer (SPY)
- After-Hours Stock Movers 12/05: (TXMD) (COUP) (BOBE) Higher; (SB) (LXRX) (STWD) Lower (more...)
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Streetinsider.com's Hot Lunchtime Reads 12/1: (ANGI) (CAT) (BLUE) (SRPT)
- Notable Analyst Rating Changes 11/30: (UNH) (CE) (GS) Upgraded; (GRA) (FCX) (DLTH) Downgraded
- Trading Radar for 12/5: GW Pharma (GWPH), KongZhong (KZ) Report
Create E-mail Alert Related CategoriesSpecial Reports
Related EntitiesDeutsche Bank, BTIG
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!